<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="4177" id="root" date="1996-08-20" xml:lang="en">
<title>CANADA: Biomira, Neoprobe in pact.</title>
<headline>Biomira, Neoprobe in pact.</headline>
<dateline>TORONTO 1996-08-20</dateline>
<text>
<p>Biomira Inc and Neoprobe Corp said on Tuesday they signed a deal under which Biomira granted Neoprobe an exclusive worldwide license to use Biomira's radiolabeled murine monoclonal antibody MAb-170 in Neoprobe's RIGS technology for surgical detection of breast cancer.</p>
<p>Neoprobe plans to conduct a Phase I clinical trial involving up to 45 women who are undergoing breast conserving surgery, the company said.</p>
<p>Roughly 73,000 cancer patients have this type of surgery every year in the U.S. and that number is expected to rise to more than 87,000 a year in the next 10 years.  </p>
<p>In Neoprobe's RIGS approach, the Biomira antibody is injected into the patient before surgery.</p>
<p>It then attaches to the cancerous tissue and the surgeon uses Neoprobe's hand-held gamma-detecting probe to identify where the antibody has accumulated in diseased tissue which may not have been recognizable by touch or sight.</p>
<p>Neoprobe has received an upfront fee and will get milestone payments and royalties upon commercialization of a RIGS product using the Biomira molecule. Neoprobe has the option to license another Biomira molecule, MAb-174.</p>
<p>-- Reuters Toronto Bureau (416) 941-8100</p>
</text>
<copyright>(c) Reuters Limited 1996</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="CANA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-20"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-20"/>
  </code>
  <code code="I37200">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-20"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C33">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-20"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-20"/>
  </code>
</codes>
<dc element="dc.date.created" value="1996-08-20"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1996-08-20"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="TORONTO"/>
<dc element="dc.creator.location.country.name" value="CANADA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
